LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • Primary Antibodies
    • Secondary Antibodies
    • IHC-plus Antibodies
    • Isotype Control Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Anti-TRAF3IP2 / ACT1 Antibody (N-Terminus) LS-C186619

Ordering

Wt. Vol. Conc. Price
100 µg - 0.5 mg/ml $385

LSBio (Direct) LSBio (Direct)
206-374-1102
866-206-6909
Orders@LSBio.com
 

TRAF3IP2 / ACT1 Antibody LS-C186619 Images

[click image for a larger image and more details]
Western Blot
TRAF3IP2 antibody (2 ug/ml) staining of MCF7 lysate (35 ug protein in RIPA buffer).

100% Guaranteed 100% Guaranteed
Goat Polyclonal to Human TRAF3IP2 / ACT1
Human
Western blot, ELISA
Unconjugated

Details

Human TRAF3IP2 / ACT1
Goat
Human (tested or 100% immunogen sequence identity)
Polyclonal
Immunoaffinity purified

Applications

Western blot (1 - 3 µg/ml), ELISA (1:2000)

Specificity and Use

TRAF3IP2 / ACT1 antibody was raised against synthetic peptide C-PDTGHDSDKSDQ from the C or N-terminus of human TRAF3IP2 / ACT1 (NP_671733.1; NP_679211.1). Percent identity by BLAST analysis: Hamster, Dog (83%).
LS-E26462 - Lyophilized - 100 µg - $145.00
N-Terminus
Human TRAF3IP2 / ACT1. This antibody is expected to recognise both reported isoforms (NP_671733.1 and NP_679211.1).
Peptide ELISA: antibody detection limit dilution 1:2000. Western blot: Approx 65kD band observed in lysates of cell line MCF7 (calculated MW of 64.7kD according to NP_671733.1). Recommended concentration: 1-3 ug/ml.

Packaging

Tris-buffered saline, pH 7.3, 0.5% BSA, 0.02% sodium azide
Store at -20°C. Minimize freezing and thawing.
For research use only.

About TRAF3IP2 / ACT1

O43734 NM_147200 NP_671733.1

TRAF3IP2 Antibody, C6orf2 Antibody, C6orf4 Antibody, C6orf5 Antibody, CIKS Antibody, DKFZP586G0522 Antibody, Connection to IKK and SAPK/JNK Antibody, ACT1 Antibody, Adapter protein CIKS Antibody, NFkB-activating protein ACT1 Antibody, PSORS13 Antibody, TRAF3-interacting protein 2 Antibody, C6orf6 Antibody, TRAF3 interacting protein 2 Antibody

Nuclear factor kappa B (NF-kB) is a ubiquitous transcription factor and an essential mediator of gene expression during activation of immune and inflammatory responses. NF-kB mediates the expression of a great variety of genes in response to extracellular stimuli. NF-kB associates with IkB proteins in the cell cytoplasm, which inhibit NF-kB activity. IkB is phosphorylated by IkB kinase (IKK) complex that contains IKKa, IKKb, and IKKg.

Western Blot

Western Blot
TRAF3IP2 antibody (2 ug/ml) staining of MCF7 lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
 

Requested From: United States
Date Requested: 7/22/2014
Copyright © 2014 LifeSpan BioSciences, Inc. All Rights Reserved